We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
-5.54%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$79.9B
AUM Growth
-$6.45B
(-7.5%)
Cap. Flow
-$1.92B
Cap. Flow
% of AUM
-2.4%
Top 10 Holdings %
Top 10 Hldgs %
28.59%
Holding
1,534
New
77
Increased
494
Reduced
709
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$128M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$124M |
| 3 |
Broadridge
BR
|
+$105M |
| 4 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$101M |
| 5 |
Motorola Solutions
MSI
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$332M |
| 2 |
NVIDIA
NVDA
|
+$268M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$190M |
| 4 |
TSMC
TSM
|
+$149M |
| 5 |
Cisco
CSCO
|
+$138M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.97% |
| 2 | Technology | 17.33% |
| 3 | Healthcare | 10.95% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Bio-Rad Laboratories Class A
BIO
$8.96B
| $2.16M | ﹤0.01% |
5,166
-60
| -1% | -$29.9K |
|
|
ABCM
977
DELISTED
Abcam PLC
ABCM
| $2.16M | ﹤0.01% |
147,539
+83,109
| +129% | +$1.24M |
|
|
MPT
978
Medical Properties Trust
MPT
$2.75B
| $2.16M | ﹤0.01% |
188,626
+560
| +0.3% | +$8.48K |
|
|
PPBI
979
DELISTED
Pacific Premier Bancorp
PPBI
| $2.15M | ﹤0.01% |
68,946
-4,656
| -6% | -$152K |
|
980
MYR Group
MYRG
$5.26B
| $2.15M | ﹤0.01% |
25,200
-15,500
| -38% | -$1.42M |
|
|
IPOD
981
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $2.15M | ﹤0.01% |
214,300
| – | – |
|
|
CGC
982
Canopy Growth
CGC
$404M
| $2.12M | ﹤0.01% |
76,022
+9,385
| +14% | +$289K |
|
983
Home BancShares
HOMB
$6.27B
| $2.12M | ﹤0.01% |
93,056
-5,254
| -5% | -$122K |
|
984
SAP
SAP
$219B
| $2.1M | ﹤0.01% |
26,153
+2,513
| +11% | +$222K |
|
985
Lamb Weston
LW
$7.29B
| $2.08M | ﹤0.01% |
26,607
-100
| -0.4% | -$7.82K |
|
986
Okta
OKTA
$24.6B
| $2.06M | ﹤0.01% |
36,267
-423,199
| -92% | -$36.4M |
|
987
Employers Holdings
EIG
$910M
| $2.05M | ﹤0.01% |
59,400
-46,500
| -44% | -$1.82M |
|
988
Signet Jewelers
SIG
$3.69B
| $2.05M | ﹤0.01% |
+36,600
| New | +$2.2M |
|
989
Acadia Pharmaceuticals
ACAD
$4.39B
| $2.04M | ﹤0.01% |
126,660
+15,300
| +14% | +$248K |
|
990
SiriusXM
SIRI
$10.2B
| $2.04M | ﹤0.01% |
35,219
-937
| -3% | -$58.9K |
|
991
Copa Holdings
CPA
$5.96B
| $2.04M | ﹤0.01% |
30,424
-1,364
| -4% | -$94.9K |
|
992
Regency Centers
REG
$14.7B
| $2.04M | ﹤0.01% |
38,267
+100
| +0.3% | +$6.12K |
|
993
Heritage Financial
HFWA
$1.23B
| $2.03M | ﹤0.01% |
+75,400
| New | +$1.99M |
|
|
SA
994
Seabridge Gold
SA
$2.84B
| $2.02M | ﹤0.01% |
172,830
-202
| -0.1% | -$2.56K |
|
995
Black Hills Corp
BKH
$5.42B
| $2.02M | ﹤0.01% |
29,200
-5,200
| -15% | -$390K |
|
996
Whirlpool
WHR
$2.54B
| $2.02M | ﹤0.01% |
14,665
-260
| -2% | -$41.4K |
|
|
CSW
997
CSW Industrials
CSW
$5.6B
| $2.01M | ﹤0.01% |
16,660
+2,000
| +14% | +$245K |
|
998
Live Oak Bancshares
LOB
$2.03B
| $2M | ﹤0.01% |
64,674
+3,932
| +6% | +$141K |
|
|
HTO
999
H2O America
HTO
$2.56B
| $2M | ﹤0.01% |
34,090
-2,278
| -6% | -$147K |
|
1000
Fate Therapeutics
FATE
$291M
| $2M | ﹤0.01% |
89,526
-22,714
| -20% | -$656K |
|
Similar funds
VAM
TD Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, TD Asset Management held 1,534 positions worth $79.9B, down 7.5% from $86.3B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
TD Asset Management's Q3 2022 filing shows 77 new, 494 increased, 709 reduced and 60 closed positions. Its largest new stake was Eagle Materials: 154,517 shares worth $16.4M. The largest sale was Atlassian, an estimated $332M.
By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Technology and Healthcare.
- TD Asset Management's largest Q3 2022 buy was Eagle Materials: 154,517 shares worth $16.4M.
- TD Asset Management added most to Thermo Fisher Scientific in Q3 2022, an estimated $128M increase.
- TD Asset Management's biggest Q3 2022 reduction was NVIDIA, cutting an estimated $268M.
- TD Asset Management fully exited Atlassian in Q3 2022, selling an estimated $332M.
- TD Asset Management's ten largest holdings make up 29% of its $79.9B portfolio in Q3 2022.
- TD Asset Management opened 77 new positions and closed 60 in Q3 2022.
- TD Asset Management's portfolio value fell 7.5% quarter-over-quarter to $79.9B.
Based on TD Asset Management's 13F filing for Q3 2022, filed 7 Nov 2022.